Thromboelastography MightBe More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19.
作者信息
Brubaker Lisa, Mortus Jared, Cruz Miguel, Trautner Barbara, Loor Michele, Rosengart Todd
机构信息
Houston, TX.
出版信息
J Am Coll Surg. 2021 Jun;232(6):1021-1022. doi: 10.1016/j.jamcollsurg.2021.03.005. Epub 2021 Apr 7.
Abstract
摘要
相似文献
1
Thromboelastography MightBe More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19.在新冠肺炎危重症患者中，血栓弹力图可能比纤维蛋白溶解疗法更适用于指导抗凝治疗。
J Am Coll Surg. 2021 Jun;232(6):1021-1022. doi: 10.1016/j.jamcollsurg.2021.03.005. Epub 2021 Apr 7.
2
Thromboelastography Might Be More Applicable to Guide Anticoagulant Therapy than Fibrinolytic Therapy in Critically Ill Patients with COVID-19.在新冠重症患者中，血栓弹力图可能比纤维蛋白溶解疗法更适用于指导抗凝治疗。
J Am Coll Surg. 2021 Feb;232(2):227-229. doi: 10.1016/j.jamcollsurg.2020.11.003. Epub 2020 Nov 25.
3
Thromboelastography-Guided Anticoagulant Therapy for the Double Hazard of Thrombohemorrhagic Events in COVID-19: A Report of 3 Cases.血栓弹力图引导的抗凝治疗 COVID-19 双重血栓出血事件风险：3 例报告
Am J Case Rep. 2021 Apr 1;22:e931080. doi: 10.12659/AJCR.931080.
4
The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series.血栓弹力描记术（TEG）在 COVID-19 危重症中的价值：病例系列说明。
J Cardiothorac Vasc Anesth. 2022 Aug;36(8 Pt A):2536-2543. doi: 10.1053/j.jvca.2021.10.015. Epub 2021 Oct 16.
5
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography.COVID-19 患者血浆通过血栓弹力描记法测量显示对 tPA 诱导的纤维蛋白溶解的抵抗。
J Thromb Thrombolysis. 2021 Oct;52(3):766-771. doi: 10.1007/s11239-021-02438-y. Epub 2021 Apr 7.
6
Normal Response to Fibrinolytic Challenge in COVID-19 Patients: Viscoelastic Evaluation Using Urokinase-Modified Thromboelastography.COVID-19患者对纤溶挑战的正常反应：使用尿激酶改良血栓弹力图的粘弹性评估
J Am Coll Surg. 2021 May;232(5):803-805. doi: 10.1016/j.jamcollsurg.2021.02.004. Epub 2021 Mar 13.
7
Effectiveness and safety of fibrinolytic therapy in critically ill patients with COVID-19 with ARDS: protocol for a prospective meta-analysis.新冠肺炎合并急性呼吸窘迫综合征危重症患者溶栓治疗的有效性和安全性：一项前瞻性荟萃分析方案。
BMJ Open. 2022 Sep 26;12(9):e063855. doi: 10.1136/bmjopen-2022-063855.
8
Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.严重 SARS-CoV-2 感染患者血浆 D-二聚体水平的改善可作为纤维蛋白溶解抑制的指标：病例报告。
Medicine (Baltimore). 2021 Apr 16;100(15):e25255. doi: 10.1097/MD.0000000000025255.
9
The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.接受治疗性抗凝治疗的危重症 COVID-19 患者的止血情况：一项观察性研究。
Medicine (Baltimore). 2020 Nov 20;99(47):e23365. doi: 10.1097/MD.0000000000023365.
10
Albumin Infusion in Critically Ill COVID-19 Patients: Hemodilution and Anticoagulation.重症 COVID-19 患者的白蛋白输注：血液稀释与抗凝
Int J Mol Sci. 2021 Jul 1;22(13):7126. doi: 10.3390/ijms22137126.
本文引用的文献
1
Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill.新冠肺炎危重症患者血栓弹力图结果与高凝综合征。
JAMA Netw Open. 2020 Jun 1;3(6):e2011192. doi: 10.1001/jamanetworkopen.2020.11192.
2
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.严重 COVID-19 感染中纤维蛋白溶解关闭与血栓栓塞事件的相关性。
J Am Coll Surg. 2020 Aug;231(2):193-203.e1. doi: 10.1016/j.jamcollsurg.2020.05.007. Epub 2020 May 15.
3
Acute limb ischemia in patients with COVID-19 pneumonia.新型冠状病毒肺炎患者的急性肢体缺血
J Vasc Surg. 2020 Dec;72(6):1864-1872. doi: 10.1016/j.jvs.2020.04.483. Epub 2020 Apr 29.
4
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.COVID-19 相关严重高凝状态与急性呼吸衰竭入住重症监护病房患者。
Thromb Haemost. 2020 Jun;120(6):998-1000. doi: 10.1055/s-0040-1710018. Epub 2020 Apr 21.
5
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态：血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.
Zotero 插件